BTG wins US approval for BC Bead Lumi

Mon, 14th Dec 2015 08:14

(ShareCast News) - Specialist pharmaceutical firm BTG said it had won US regulatory approval for its LC Bead Lumi radiation treatment.The company added that a trial of its PneumRx endobronchial coil implant for severe emphysema had produced positive results with all primary and secondary endpoints of the study met.

Related Shares

More News

8 Sep 2020 13:34

Tuesday broker round-up

(Sharecast News) - Hargreaves Lansdown: Berenberg upgrades to buy with a target price of 1,915.0p.

24 Aug 2020 10:57

Monday broker round-up

(Sharecast News) - Dechra Pharmaceuticals: Liberum initiates at sell with a target price of 2,740p.

20 May 2020 13:56

Wednesday broker round-up

(Sharecast News) - Great Portland Estates: Peel Hunt downgrades to reduce with a target price of 630p.

18 Feb 2020 13:26

Tuesday broker round up

(Sharecast News) - Severn Trent: JP Morgan upgrades to neutral with a target price of 2,550p.

18 Feb 2020 10:50

BT set to scrap pay-TV packages and offer monthly prime subscriptions

(Sharecast News) - Broadcaster BT is set to scrap pay-TV packages for monthly prime content subscriptions, granting the flexibility that other streami...